See every side of every news story
Published loading...Updated

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Acquired by Xponance Inc.

Summary by defenseworld.net
Xponance Inc. increased its position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 14.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,585 shares of the biopharmaceutical company’s stock after buying an additional 1,434 shares during the quarter. Xponance Inc.’s holdings in ACADIA Pharmaceuticals were worth $192,000 at the end of the mo…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

defenseworld.net broke the news in on Monday, July 21, 2025.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.